Park Avenue Securities’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Buy |
34,363
+2,535
| +8% | +$39.2K | ﹤0.01% | 1039 |
|
|
2025
Q1 | $473K | Buy |
31,828
+4,177
| +15% | +$62.1K | 0.01% | 874 |
|
|
2024
Q4 | $366K | Buy |
27,651
+6,094
| +28% | +$80.7K | ﹤0.01% | 1199 |
|
|
2024
Q3 | $307K | Sell |
21,557
-6,670
| -24% | -$95K | ﹤0.01% | 1172 |
|
|
2024
Q2 | $365K | Sell |
28,227
-617
| -2% | -$7.98K | ﹤0.01% | 1111 |
|
|
2024
Q1 | $401K | Sell |
28,844
-2,897
| -9% | -$40.3K | 0.01% | 1061 |
|
|
2023
Q4 | $453K | Sell |
31,741
-5,736
| -15% | -$81.9K | 0.01% | 953 |
|
|
2023
Q3 | $580K | Buy |
37,477
+10,255
| +38% | +$159K | 0.01% | 780 |
|
|
2023
Q2 | $428K | Buy |
27,222
+2,001
| +8% | +$31.5K | 0.01% | 642 |
|
|
2023
Q1 | $416K | Buy |
25,221
+1,268
| +5% | +$20.9K | 0.01% | 626 |
|
|
2022
Q4 | $374K | Buy |
23,953
+3,507
| +17% | +$54.8K | 0.01% | 886 |
|
|
2022
Q3 | $265K | Buy |
20,446
+1,197
| +6% | +$15.5K | 0.01% | 956 |
|
|
2022
Q2 | $270K | Buy |
19,249
+3,708
| +24% | +$52K | 0.01% | 960 |
|
|
2022
Q1 | $223K | Buy |
15,541
+2,893
| +23% | +$41.5K | ﹤0.01% | 1057 |
|
|
2021
Q4 | $172K | Buy |
12,648
+280
| +2% | +$3.81K | ﹤0.01% | 1078 |
|
|
2021
Q3 | $203K | Sell |
12,368
-336
| -3% | -$5.52K | ﹤0.01% | 993 |
|
|
2021
Q2 | $214K | Buy |
12,704
+344
| +3% | +$5.8K | ﹤0.01% | 968 |
|
|
2021
Q1 | $226K | Buy |
12,360
+1,539
| +14% | +$28.1K | 0.01% | 884 |
|
|
2020
Q4 | $197K | Buy |
+10,821
| New | +$197K | 0.01% | 819 |
|